Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin (Q35285763)

7 August 2017

title

Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin (English)

1 reference

7 August 2017

main subject

gram-positive bacteria

0 references

author name string

Greenberg RN

series ordinal

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 December 1990

1 reference

Antimicrobial Agents and Chemotherapy

7 August 2017

published in

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

7 August 2017

page(s)

2392-2397

1 reference

Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp.

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172067

In vitro activity and human pharmacokinetics of teicoplanin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172067

In vitro activity of teichomycin compared with those of other antibiotics

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172067

Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172067

Antibiotic susceptibility testing by a standardized single disk method

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172067

Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172067

Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172067

Influence of protein binding on therapeutic efficacy of cefoperazone

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172067

Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172067

Comparative in vitro activities of teicoplanin, vancomycin, oxacillin, and other antimicrobial agents against bacteremic isolates of gram-positive cocci

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172067

Teicoplanin in the treatment of gram-positive-bacterial endocarditis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172067

Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172067

Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172067

Serum Dilution Test for Bactericidal Activity. II. Standardization and Correlation with Antimicrobial Assays and Susceptibility Tests

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172067

Time-kill studies with oxacillin, vancomycin, and teicoplanin versus Staphylococcus aureus

27 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2150908

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/2150908

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparison of the solid phase enzyme receptor assay (SPERA) and the microbiological assay for teicoplanin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2150908

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.34.12.2392

1 reference

7 August 2017

1 reference

7 August 2017

1 reference